Terms: = Liver cancer AND ATP2B3, PMCA3, 492, ENSG00000067842
159 results:
1. Effect of comprehensive nursing care for the liver cancer patients undergoing interventional therapy in China: A systematic review and meta-analysis.
Zhang S; Li N; Mao X; Yang D
Int J Nurs Pract; 2024 Apr; 30(2):e13243. PubMed ID: 38351900
[TBL] [Abstract] [Full Text] [Related]
2. Impact of Commission on cancer Accreditation on cancer Survival: A Surveillance, Epidemiology, and End Results (SEER) Database Analysis.
Ahmed A; Whittington J; Shafaee Z
Ann Surg Oncol; 2024 Apr; 31(4):2286-2294. PubMed ID: 38093167
[TBL] [Abstract] [Full Text] [Related]
3. Prognostic value of circulating tumor cells associated with white blood cells in solid cancer: a systematic review and meta-analysis of 1471 patients with solid tumors.
Ju M; Gao Z; Gu G; Huang H; Sun A; Zheng C; Li H; Zhang Y; Li K
BMC Cancer; 2023 Dec; 23(1):1224. PubMed ID: 38087278
[TBL] [Abstract] [Full Text] [Related]
4. Cuproptosis-related molecular patterns and gene (ATP7A) in hepatocellular carcinoma and their relationships with tumor immune microenvironment and clinical features.
Li S; Weng J; Xiao C; Lu J; Cao W; Song F; He Z; Zhang P; Zhu Z; Xu J
Cancer Rep (Hoboken); 2023 Dec; 6(12):e1904. PubMed ID: 37885090
[TBL] [Abstract] [Full Text] [Related]
5. Effect of Verapamil, a P-glycoprotein-1 and Cytochrome P450 3A4 Inhibitor, on Pharmacokinetics and Metabolic Stability of Ripretinib: A Drug-Drug Interaction Study in Rats.
Mudavath S; Ashok D
Eur J Drug Metab Pharmacokinet; 2023 Nov; 48(6):733-746. PubMed ID: 37831396
[TBL] [Abstract] [Full Text] [Related]
6. hsa_circ_0129047 Upregulates LYVE1 to Inhibit Hepatocellular Carcinoma Progression by Sponging miR-492.
Feng Z; Wu J
Dis Markers; 2023; 2023():6978234. PubMed ID: 37810197
[TBL] [Abstract] [Full Text] [Related]
7. A nationwide study on the current treatment status and natural prognosis of hepatocellular carcinoma in elderly.
Yoo JJ; Lee J; Choi GH; Lee MW; Park DA
Sci Rep; 2023 Sep; 13(1):14584. PubMed ID: 37666940
[TBL] [Abstract] [Full Text] [Related]
8. Tumor burden score-AFP-albumin-bilirubin grade score predicts the survival of patients with hepatocellular carcinoma after liver resection.
Qiu ZC; Li C; Zhang Y; Xie F; Yu Y; Leng SS; Chen TH; Wen TF
Langenbecks Arch Surg; 2023 Jun; 408(1):250. PubMed ID: 37382724
[TBL] [Abstract] [Full Text] [Related]
9. Gepliver: an integrative liver expression atlas spanning developmental stages and liver disease phases.
Li Z; Zhang H; Li Q; Feng W; Jia X; Zhou R; Huang Y; Li Y; Hu Z; Hu X; Zhu X; Huang S
Sci Data; 2023 Jun; 10(1):376. PubMed ID: 37301898
[TBL] [Abstract] [Full Text] [Related]
10. Current status and future perspectives in dysregulated miR-492.
Shen J; Si J; Wang Q; Mao Y; Gao W; Duan S
Gene; 2023 Aug; 877():147518. PubMed ID: 37295631
[TBL] [Abstract] [Full Text] [Related]
11. Association of gamma-glutamyl transferase concentrations with all-cause and cause-specific mortality in Chinese adults with type 2 diabetes.
Guan H; Liu K; Fan X; Yu H; Qin Y; Yang J; Zhu Z; Shen C; Pan E; Lu Y; Zhou J; Su J; Wu M
J Diabetes; 2023 Aug; 15(8):674-684. PubMed ID: 37161588
[TBL] [Abstract] [Full Text] [Related]
12. The systemic immune-inflammation index was non-linear associated with all-cause mortality in individuals with nonalcoholic fatty liver disease.
Zhao E; Cheng Y; Yu C; Li H; Fan X
Ann Med; 2023 Dec; 55(1):2197652. PubMed ID: 37052341
[TBL] [Abstract] [Full Text] [Related]
13. Preoperative systemic inflammatory response index predicts the prognosis of patients with hepatocellular carcinoma after liver transplantation.
Cui S; Cao S; Chen Q; He Q; Lang R
Front Immunol; 2023; 14():1118053. PubMed ID: 37051235
[TBL] [Abstract] [Full Text] [Related]
14. Coffee, Green Tea Intake, and the Risk of Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis of Observational Studies.
Yu J; Liang D; Li J; Liu Z; Zhou F; Wang T; Ma S; Wang G; Chen B; Chen W
Nutr Cancer; 2023; 75(5):1295-1308. PubMed ID: 37038314
[TBL] [Abstract] [Full Text] [Related]
15. Treatment and outcomes of immune checkpoint inhibitors-associated colitis/diarrhea: A systematic review and meta-analysis.
Ding M; Zhang X; Wang J; Gao F; Zheng X; Yuan J; Qi X
Dig Liver Dis; 2023 Dec; 55(12):1621-1631. PubMed ID: 36894390
[TBL] [Abstract] [Full Text] [Related]
16. Resection of NAFLD/NASH-related Hepatocellular Carcinoma (HCC): Clinical Features and Outcomes Compared with HCC Due to Other Etiologies.
Pal Chaudhary S; Reyes S; Chase ML; Govindan A; Zhao L; Luther J; Bhan I; Bethea E; Franses JW; Paige Walsh E; Anne Dageford L; Kimura S; Elias N; Yeh H; Markman J; Bozorgzadeh A; Tanabe K; Ferrone C; Zhu AX; Andersson K; Thiim M; Antonio Catalano O; Kambadakone A; Vagefi PA; Qadan M; Pratt D; Hashemi N; Corey KE; Misdraji J; Goyal L; Clark JW
Oncologist; 2023 Apr; 28(4):341-350. PubMed ID: 36763374
[TBL] [Abstract] [Full Text] [Related]
17. Seven centimeters as an optimal cutoff value for prognosis stratification in large monofocal hepatocellular carcinoma.
Yen YH; Li WF; Kee KM; Wang CC; Cheng YF; Lu SN; Hung CH; Liu YW; Hu TH
Langenbecks Arch Surg; 2023 Jan; 408(1):12. PubMed ID: 36609929
[TBL] [Abstract] [Full Text] [Related]
18. Diet and Risk of Non-Alcoholic Fatty liver Disease, Cirrhosis, and liver cancer: A Large Prospective Cohort Study in UK Biobank.
Guo W; Ge X; Lu J; Xu X; Gao J; Wang Q; Song C; Zhang Q; Yu C
Nutrients; 2022 Dec; 14(24):. PubMed ID: 36558494
[TBL] [Abstract] [Full Text] [Related]
19. Sustained viral response and relapse after discontinuation of oral antiviral drugs in HBeAg-positive patients with chronic hepatitis B infection.
Sun F; Li Z; Hu L; Deng W; Jiang T; Wang S; Bi X; Lu H; Yang L; Lin Y; Zeng Z; Shen G; Liu R; Chang M; Wu S; Gao Y; Hao H; Xu M; Chen X; Zhang L; Lu Y; Dong J; Xie Y; Li M
Front Immunol; 2022; 13():1082091. PubMed ID: 36505492
[TBL] [Abstract] [Full Text] [Related]
20. Elevation of circulating TNF receptor 2 in cancer: A systematic meta-analysis for its potential as a diagnostic cancer biomarker.
Kartikasari AER; Cassar E; Razqan MAM; Szydzik C; Huertas CS; Mitchell A; Plebanski M
Front Immunol; 2022; 13():918254. PubMed ID: 36466914
[TBL] [Abstract] [Full Text] [Related]
[Next]
